|Opens resource in a 2nd browser window.|
AcuVector Group, Inc.
(AGI) “AcuVector Group, Inc. has developed advanced technologies to formulate and test gene-therapy vaccines and is in the process of developing commercial product lines based on these exciting technological breakthroughs.”
Avigen develops gene therapy products derived from the adeno associated virus for treating inherited and acquired diseases such as HIV and sickle cell anemia.
Core technologies are focused on the development of gene therapy products that promote angiogenesis, enhance myocardial
adrenergic signaling and stimulate heart
Gene Therapy Systems, Inc.
(GTS) “Gene Therapy Systems, Inc. is focused on developing revolutionary technology platforms in gene cloning and expression, and in pioneering cell-specific delivery tools.”
Genespan develops tools and research for gene therapy, accelerated drug discovery, and enhanced affordable therapy.
Genetix Pharmaceuticals, Inc.
Genetix Pharmaceuticals develops gene-based therapies for treatment of serious human diseases.
GenVec, Inc. focuses on the development and commercialization of novel gene-based therapies for the treatment of major medical needs in cardiovascular disease, cancer and other therapeutic areas.
Osiris Therapeutics is a privately held development stage company, engaged in the development and commercialization of cellular therapeutic products for the regeneration and functional restoration of damaged or diseased tissue.
Ostex International, Inc.
Ostex International, Inc. is engaged in the discovery and commercialization of products associated with osteoporosis and other collagen-related diseases.
Q-One Biotech Ltd.
Q-One Biotech provides specialist safety testing and process validation services, cGMP contract manufacturing of cell banks, vaccines and gene therapy products to the biopharmaceutical industry.
Top of Page